Tsumura & Co. (FRA:TSUA)

Market Cap	1.47B -27.3%
Revenue (ttm)	1.03B +10.3%
Net Income	157.60M +7.0%
EPS	2.10 +8.2%
Shares Out	n/a
PE Ratio	9.34
Forward PE	n/a
Dividend	68.41 (367.81%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Average Volume	n/a
Open	18.70
Previous Close	18.70
Day's Range	18.70 - 18.70
52-Week Range	18.60 - 23.00
Beta	n/a
RSI	36.10
Earnings Date	May 13, 2026

About Tsumura & Co.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal and throat inflammation symptoms. It also offers over-the-counter Kampo medicines. The company was founded in 1893 and is headquartered in Tokyo, Japan.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1893
• Employees: 4,272
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TSUA

Financial Performance

In fiscal year 2025, Tsumura & Co.'s revenue was 181.09 billion, an increase of 20.05% compared to the previous year's 150.85 billion. Earnings were 32.43 billion, an increase of 94.10%.

Financial numbers in JPY